Pancreatic Diseases
Conditions
Brief summary
The purpose of this study is to collect blood samples to detect potential markers of pancreatic cancer in the blood and link these findings to medical and health information. Information from this study may help to provide insight into the detection of pancreas cancer in the blood before it can be found by other methods or provide a method of monitoring the status of pancreatic cancer throughout a treatment course. Another purpose of this study is to collect blood to create a biobank.
Interventions
None listed
Sponsors
Abramson Cancer Center at Penn Medicine
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. The subject must be a patient at the Hospital of the University of Pennsylvania * The subject must be under evaluation and/or treatment for a pancreatic disease * The subject must be under evaluation and/or treatment for a non-pancreatic disease. For example, patients undergoing routine colonoscopy within the clinical practice will be asked to consent to provide control samples. 2. The subject must be able to provide informed consent or have an acceptable surrogate capable of giving consent on the subject's behalf 3. The subject must be 18 years of age or older
Exclusion criteria
1. The subject or acceptable surrogate does not provide informed consent 2. Subject is a prisoner 3. Subject is under 18 years of age
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Collection of blood and tissue samples from subjects with pancreatic diseases | 3 years |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORPeter O'Dwyer, MD
Abramson Cancer Center at Penn Medicine
Outcome results
None listed